Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China flag China · Delayed Price · Currency is CNY
19.01
-0.54 (-2.76%)
Nov 17, 2026, 3:00 PM CST

SHA:688062 Revenue

Mabwell (Shanghai) Bioscience had revenue of 308.48M CNY in the quarter ending September 30, 2026, a decrease of -33.61%. This brings the company's total for the last twelve months to 717.80M, up 14.94% year-over-year. In the year 2025, Mabwell (Shanghai) Bioscience had annual revenue of 662.52M with 231.62% growth. That makes Mabwell (Shanghai) Bioscience the 22,146th largest company in the world by revenue and 4,040th in China.

Revenue (ttm)
717.80M
Revenue Growth
+14.94%
P/S Ratio
11.65
Revenue / Employee
541.74K
Employees
1,356
Market Cap
8.27B

Revenue Chart

Revenue by Geography

  • Mainland China 582.13M 87.9%
  • Other Regions 80.38M 12.1%
Fiscal year ended Dec 31, 2025 See the full SHA:688062 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025662.52M462.73M231.62%
Dec 31, 2024199.78M71.95M56.28%
Dec 31, 2023127.84M100.11M361.03%
Dec 31, 202227.73M11.50M70.88%
Dec 31, 202116.23M10.92M206.03%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.